Vyne Therapeutics Inc.

08/12/2021 | Press release | Distributed by Public on 08/12/2021 06:37

VYNE Therapeutics Reports Second Quarter 2021 Financial Results and Announces New Strategic Direction to Develop Treatments for Immunological and Inflammatory Diseases (Form 8-K)